Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544164 · ClinicalTrials.gov registry record
Assessing Respiratory Rate and Tidal Volume Delivery During Manual Ventilation
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 52
- Enrollment target
NCT03544164: Completed study, sponsored by Rush University Medical Center.
NCT03544164 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03544164 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Excessive minute ventilation for patients who experience cardiac arrest may cause pulmonary injury and decrease the overall effectiveness of cardiopulmonary resuscitation (CPR). Although clinicians are trained with the correct technique for manual ventilation, evidence still shows that clinicians tend to deliver a higher respiratory rate than recommended during CPR. Little is known about tidal volume delivery during CPR; either the amount of volume give or even the impact of tidal volume on the effectiveness of CPR. There are many factors that may influence variations of tidal volumes and RR during CPR. These factors include distractions in the room (noise/cross talk), inability to assess tidal volume delivery, anxiety, and stress of the situation. This study will evaluate tidal volume and respiratory rate (RR) delivery during a simulated CPR situation. Participants will be asked to provide care for an intubated adult patient in cardiac arrest, which will include all components of advanced cardiac life support training.
Primary Outcome
Amount of volume delivered in milliliters per squeeze of the resuscitation device
Interventions
- OTHER Manual Ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-07-07 |
What the finished NCT03544164 record still lists
NCT03544164 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Manual Ventilation is the first listed.
NCT03544164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03544164 about?
NCT03544164 is a clinical study titled "Assessing Respiratory Rate and Tidal Volume Delivery During Manual Ventilation". Excessive minute ventilation for patients who experience cardiac arrest may cause pulmonary injury and decrease the overall effectiveness of cardiopulmonary resuscitation (CPR). Although clinicians are trained with the correct technique for manual ventilation, evidence still shows that clinicians te...
What is the current status of trial NCT03544164?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2018-05-07. Estimated completion is 2019-07-07.
What interventions are being tested in trial NCT03544164?
The interventions under investigation include: Manual Ventilation (OTHER).
Who is sponsoring clinical trial NCT03544164?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI